Whei‐Mei Wu

535 total citations
20 papers, 398 citations indexed

About

Whei‐Mei Wu is a scholar working on Molecular Biology, Pharmaceutical Science and Cellular and Molecular Neuroscience. According to data from OpenAlex, Whei‐Mei Wu has authored 20 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmaceutical Science and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Whei‐Mei Wu's work include Advancements in Transdermal Drug Delivery (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Dermatology and Skin Diseases (3 papers). Whei‐Mei Wu is often cited by papers focused on Advancements in Transdermal Drug Delivery (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Dermatology and Skin Diseases (3 papers). Whei‐Mei Wu collaborates with scholars based in United States, Japan and Iceland. Whei‐Mei Wu's co-authors include Nicholas Bodor, László Prókai, Pascal Druzgala, Þorsteinn Loftsson, Nicholas Bodor, Teruo MURAKAMI, G. Somogyi, Péter Buchwald, Sung‐Hwa Yoon and Hassan H. Farag and has published in prestigious journals such as Journal of Medicinal Chemistry, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Whei‐Mei Wu

20 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Whei‐Mei Wu United States 13 148 86 86 70 58 20 398
Cathie Xiang United States 13 184 1.2× 97 1.1× 120 1.4× 88 1.3× 15 0.3× 17 572
Peter G. Klimko United States 12 125 0.8× 62 0.7× 118 1.4× 22 0.3× 37 0.6× 17 426
Bryan W. Sherman United States 8 181 1.2× 36 0.4× 177 2.1× 4 0.1× 24 0.4× 11 369
Atsutoshi Ota Japan 9 136 0.9× 93 1.1× 36 0.4× 102 1.5× 9 0.2× 20 348
Rashi Rajput Australia 13 174 1.2× 8 0.1× 72 0.8× 22 0.3× 22 0.4× 21 359
Jennifer Lafontaine United States 12 176 1.2× 30 0.3× 66 0.8× 9 0.1× 11 0.2× 17 458
Andrew Payne United Kingdom 11 151 1.0× 21 0.2× 30 0.3× 5 0.1× 19 0.3× 22 408
Caroline Leriche France 10 154 1.0× 31 0.4× 45 0.5× 145 2.1× 3 0.1× 11 387
Joseph Rager United States 5 124 0.8× 16 0.2× 9 0.1× 19 0.3× 50 0.9× 9 339
Kenichi Kïshida Japan 10 230 1.6× 14 0.2× 66 0.8× 12 0.2× 49 0.8× 26 352

Countries citing papers authored by Whei‐Mei Wu

Since Specialization
Citations

This map shows the geographic impact of Whei‐Mei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whei‐Mei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whei‐Mei Wu more than expected).

Fields of papers citing papers by Whei‐Mei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whei‐Mei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whei‐Mei Wu. The network helps show where Whei‐Mei Wu may publish in the future.

Co-authorship network of co-authors of Whei‐Mei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Whei‐Mei Wu. A scholar is included among the top collaborators of Whei‐Mei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whei‐Mei Wu. Whei‐Mei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bodor, Erik T., et al.. (2016). Enhanced Activity of Topical Hydrocortisone by Competitive Binding of Corticosteroid-Binding Globulin. Journal of Pharmaceutical Sciences. 105(9). 2873–2878. 2 indexed citations
2.
Wu, Whei‐Mei, et al.. (2008). Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats. Journal of Pharmacy and Pharmacology. 60(3). 291–297. 8 indexed citations
3.
Wu, Whei‐Mei, et al.. (2005). Pharmacokinetic and Pharmacodynamic Evaluations of the Zwitterionic Metabolite of a New Series of N-Substituted Soft Anticholinergics. Pharmaceutical Research. 22(12). 2035–2044. 7 indexed citations
4.
Huang, Fenglei, et al.. (2003). Design, Pharmacokinetic, and Pharmacodynamic Evaluation of a New Class of Soft Anticholinergics. Pharmaceutical Research. 20(10). 1681–1689. 9 indexed citations
5.
Bodor, Nicholas, et al.. (2002). In Vitro and In Vivo Evaluations of Dihydroquinoline- and Dihydroisoquinoline-based Targetor Moieties for Brain-specific Chemical Delivery Systems. Journal of drug targeting. 10(1). 63–71. 15 indexed citations
6.
Yoon, Sung‐Hwa, et al.. (2002). Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH. Journal of Pharmacy and Pharmacology. 54(7). 945–950. 18 indexed citations
7.
Yoon, Sung‐Hwa, Jiaxiang Wu, Whei‐Mei Wu, László Prókai, & Nicholas Bodor. (2000). Brain-targeted chemical delivery of [Leu2, Pip3]-TRH. Bioorganic & Medicinal Chemistry. 8(5). 1059–1063. 5 indexed citations
8.
Prókai, László, Katalin Prókai-Tátrai, Ho-Seung Kim, et al.. (1999). Metabolism-Based Brain-Targeting System for a Thyrotropin-Releasing Hormone Analogue. Journal of Medicinal Chemistry. 42(22). 4563–4571. 26 indexed citations
9.
Bodor, Nicholas, et al.. (1998). Strategies To Target Kyotorphin Analogues to the Brain. Journal of Medicinal Chemistry. 41(20). 3773–3781. 48 indexed citations
10.
Bodor, Nicholas, et al.. (1997). Ocular-Specific Delivery of Timolol by Sequential Bioactivation of its Oxime and Methoxime Analogs. Journal of Ocular Pharmacology and Therapeutics. 13(5). 389–403. 12 indexed citations
11.
Reddy, Indra K., Mansoor A. Khan, Whei‐Mei Wu, & Nicholas Bodor. (1996). Permeability of a Soft Steroid, Loteprednol Etabonate, Through an Excised Rabbit Cornea. Journal of Ocular Pharmacology and Therapeutics. 12(2). 159–167. 17 indexed citations
12.
Wu, Whei‐Mei, et al.. (1996). Design, Synthesis, and Pharmacokinetic Evaluation of a Chemical Delivery System for Drug Targeting to Lung Tissue. Journal of Pharmaceutical Sciences. 85(5). 496–504. 14 indexed citations
13.
Bodor, Nicholas, László Prókai, Whei‐Mei Wu, G. Somogyi, & Hassan H. Farag. (1995). Sequential Bioactivation of Methoxime Analogs of β-Adrenergic Antagonists in the Eye. Journal of Ocular Pharmacology and Therapeutics. 11(3). 305–318. 7 indexed citations
14.
Prókai, László, Whei‐Mei Wu, G. Somogyi, & Nicholas Bodor. (1995). Ocular Delivery of the .beta.-Adrenergic Antagonist Alprenolol by Sequential Bioactivation of Its Methoxime Analog. Journal of Medicinal Chemistry. 38(11). 2018–2020. 20 indexed citations
15.
Bodor, Nicholas, Teruo MURAKAMI, & Whei‐Mei Wu. (1995). Soft Drugs 18. Oral and Rectal Delivery of Loteprednol Etabonate, a Novel Soft Corticosteroid, in Rats—for Safer Treatment of Gastrointestinal Inflammation. Pharmaceutical Research. 12(6). 869–874. 13 indexed citations
16.
Bodor, Nicholas, et al.. (1995). Soft Drugs 19. Pharmacokinetics, Metabolism and Excretion of a Novel Soft Corticosteroid, Loteprednol Etabonate, in Rats. Pharmaceutical Research. 12(6). 875–879. 19 indexed citations
17.
Yang, Hee‐Sun, Whei‐Mei Wu, & Nicholas Bodor. (1995). Soft Drugs. XX. Design, Synthesis, and Evaluation of Ultra-Short Acting Beta-Blockers. Pharmaceutical Research. 12(3). 329–336. 11 indexed citations
18.
Bodor, Nicholas, et al.. (1992). A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits. Current Eye Research. 11(6). 525–530. 30 indexed citations
19.
Loftsson, Þorsteinn, et al.. (1992). Metabolism, Distribution, and Transdermal Permeation of a Soft Corticosteroid, Loteprednol Etabonate. Pharmaceutical Research. 9(10). 1275–1278. 47 indexed citations
20.
Druzgala, Pascal, et al.. (1991). Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Current Eye Research. 10(10). 933–937. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathie Xiang Breakdown of academic impact, for papers by Peter G. Klimko Breakdown of academic impact, for papers by Bryan W. Sherman Breakdown of academic impact, for papers by Atsutoshi Ota Breakdown of academic impact, for papers by Rashi Rajput Breakdown of academic impact, for papers by Jennifer Lafontaine Breakdown of academic impact, for papers by Andrew Payne Breakdown of academic impact, for papers by Caroline Leriche Breakdown of academic impact, for papers by Joseph Rager Breakdown of academic impact, for papers by Kenichi Kïshida
Rankless by CCL
2026